Skip to content

ADMA Biologics ADMA Number of reportable segments

Number of reportable segments at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
0.3
Zymeworks logo
ZymeworksZYME
10.0%
Charles River Laboratories logo
Charles River LaboratoriesCRL
30.0%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.02B-54.5%

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:NumberOfReportableSegments.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's number of reportable segments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's number of reportable segments?
ADMA Biologics (ADMA) reported number of reportable segments of 2 in Q1 2026.
How has ADMA Biologics's number of reportable segments changed year-over-year?
ADMA Biologics's number of reportable segments increased by 300.0% year-over-year, from 0.5 to 2.
What does number of reportable segments mean?
The number of distinct business units for which the company provides separate financial reporting under accounting standards. This reflects the complexity and organizational structure of the enterprise.